Vaccine Development

Area of Science:

• Vaccinology
• Public Health Ethics
• Epidemiology

Background:

• Pandemic preparedness necessitates robust pediatric vaccine development strategies.
• Historical pandemics like smallpox, influenza, and COVID-19 highlight the need for child-focused vaccine solutions.
• Ethical considerations are paramount in the development and deployment of pediatric vaccines.

Observation:

• Examined historical pediatric vaccine development during past pandemics.
• Assessed current vaccine development for pandemic preparedness, including vaccines for smallpox/mpox, influenza, anthrax, and Ebola.
• Reviewed vaccines targeting World Health Organization priority pathogens.

Findings:

• Pediatric vaccine development for pandemics involves complex ethical considerations.
• Historical data provides insights into challenges and successes in pediatric vaccine deployment.
• The US Strategic National Stockpile includes key pandemic vaccines, with ongoing development for emerging threats.

Implications:

• Ensuring ethical frameworks for pediatric vaccine development is crucial for future pandemic response.
• Strengthening the pipeline for pediatric pandemic vaccines improves global health security.
• Continued research and ethical oversight are vital for equitable access to life-saving vaccines for children.